Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
Clinical trial NCT01364597 · COMPLETED
Trial details
- NCT number
- NCT01364597
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2022-02-03
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.